Tenofovir alafenamide (TAF)
Paul G. Auwaerter, M.D., Janessa M. Smith, PharmD, BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of HIV-1 infection as part of a single-tablet regimen (STR), Genvoya or Odefsey, or NRTI combination tablet Descovy, for adults and pediatric patients 12 years of age and older who are treatment-naive or to replace the current antiretroviral regimen in those who are virologically suppressed.
- Treatment of chronic HBV infection in adults and children ≥ 12 years with compensated liver disease.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.